Agilent Technologies
Disclosure information not submitted.
Experience a breakthrough in hematological malignancy testing using a NGS Pan Heme assay co-developed by Roswell Park and Agilent.
Thursday, November 13, 202512:00 PM - 12:30 PM EST
